Ahmet Cumaoğlu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Breast Cancer Cells

Endoplasmic Reticulum

Lipopolysaccharide Induced

Signaling Pathway

Top Venues

Turkish journal of pharmaceutical sciences

Naunyn-Schmiedeberg's archives of pharmacology

Journal of biochemical and molecular toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmad Karzoon, Mükerrem Betül Aycan, Ahmet Cumaoğlu
Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects. Naunyn-Schmiedeberg's archives of pharmacology (2024)
Büşra Karaca, Elçin Bakır, Mükerrem Betül Aycan, Ahmet Cumaoğlu, Bulent Ozpolat, Ayşe Eken
Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ERα and Wnt/β-catenin signaling pathways. Journal of biochemical and molecular toxicology 35 (11) (2021)
Ahmet Cumaoğlu, Gökçe Şeker Karatoprak, Mükerrem Betül Aycan, Müberra Koşar
Anti-inflammatory Effects of Pelargonium endlicherianum Fenzl. Extracts in Lipopolysaccharide-stimulated Macrophages. Turkish journal of pharmaceutical sciences 15 (1) (2018)
Ahmet Cumaoğlu, Aslı Özge Ağkaya, Zehra Özkul
Effect of the Lipid Peroxidation Product 4-Hydroxynonenal on Neuroinflammation in Microglial Cells: Protective Role of Quercetin and Monochloropivaloylquercetin. Turkish journal of pharmaceutical sciences 16 (1) (2018)